Master Alliance Provisions Guide (MAPGuide)

Fiocruz – AstraZeneca, COVID-19 Vaccine Technology Transfer Agreement

  • Equitable Access | Affordable pricing


Whereas, in the face of the unprecedented challenges of the SARS-CoV-2 pandemic, the Parties have the following objectives (collectively referred to herein as “the Objectives”): […]

  • Make the Licensed Product available in the Territory at affordable prices in the country of use and use Best Efforts (as defined below) to ensure that Licensed Product pricing does not prevent the health authorities in any country from being able to obtain sufficient quantities of the Licensed Product to meet requirements in the country.